Correlations of HOMA2-IR and HbA1c with algorithms derived from bioimpedance and spectrophotometric devices
- PMID: 22961656
- DOI: 10.1007/s11695-012-0683-3
Correlations of HOMA2-IR and HbA1c with algorithms derived from bioimpedance and spectrophotometric devices
Abstract
Background: Homeostasis model assessment of insulin resistance (HOMA2-IR) and HbA1c, markers of metabolic syndrome and glycemic control, were compared with Electro Sensor (ES) Complex software algorithms. ES complex software integrates data from Electro Sensor Oxi (ESO; spectrophotometry) and Electro Sensor-Body Composition (ES-BC; bioimpedance).
Methods: One hundred forty-eight Brazilian obese candidates for bariatric surgery underwent complete physical examinations, laboratory tests (fasting plasma glucose, fasting plasma insulin, and HbA1c) and ES complex assessments. HOMA2-IR was calculated from fasting plasma glucose and fasting plasma insulin using free software provided by The University of Oxford Diabetes Trial Unit. ES complex-insulin resistance (ESC-IR) and ES complex-blood glucose control (ESC-BCG) were calculated from ESO and ES-BC data using ES complex software. Correlations between HOMA2-IR and ESC-IR and between ESC-BGC and HbA1c were determined.
Results: ESC-BGC was correlated with HbA1c (r = 0.85). ESC-BCG values >3 were predictive of HbA1c > 6.5% (φ = 0.94; unweighted κ = 0.9383). ESC-IR was correlated with HOMA2-IR (r = 0.84). Patients with ESC-IR score >2.5 or >3 were more likely to have metabolic syndrome or insulin resistance, respectively, compared with HOMA2-IR value >1.4 and >1.8, respectively. ESC-IR performance was evaluated by receiver operating characteristic curves. The areas under the curve for metabolic syndrome and insulin resistance were 0.9413 and 0.9022, respectively.
Conclusion: The results of this study in Brazilian subjects with obesity suggest that ES complex algorithms will be useful in large-scale screening studies to predict insulin resistance, metabolic syndrome, and HbA1c >6.5%. Additional studies are needed to confirm these correlations in non-obese subjects and in other ethnic groups.
Similar articles
-
New approach to beta cell function screening by nitric oxide assessment of obese individuals at the population level.Int J Gen Med. 2012;5:449-54. doi: 10.2147/IJGM.S31433. Epub 2012 May 21. Int J Gen Med. 2012. PMID: 22675263 Free PMC article.
-
Glycated Hemoglobin, Fasting Insulin and the Metabolic Syndrome in Males. Cross-Sectional Analyses of the Aragon Workers' Health Study Baseline.PLoS One. 2015 Aug 4;10(8):e0132244. doi: 10.1371/journal.pone.0132244. eCollection 2015. PLoS One. 2015. PMID: 26241903 Free PMC article.
-
Antidepressant medication use and trajectories of fasting plasma glucose, glycated haemoglobin, β-cell function and insulin sensitivity: a 9-year longitudinal study of the D.E.S.I.R. cohort.Int J Epidemiol. 2015 Dec;44(6):1927-40. doi: 10.1093/ije/dyv153. Epub 2015 Aug 4. Int J Epidemiol. 2015. PMID: 26245205
-
Serum adropin levels are decreased in Chinese type 2 diabetic patients and negatively correlated with body mass index.Endocr J. 2018 Jul 28;65(7):685-691. doi: 10.1507/endocrj.EJ18-0060. Epub 2018 Apr 17. Endocr J. 2018. PMID: 29669965
-
HOMA-IR and HOMA2-IR estimation based on glycated hemoglobin as an alternative for fasting glucose.Acta Clin Belg. 2023 Aug;78(4):308-312. doi: 10.1080/17843286.2022.2160889. Epub 2022 Dec 27. Acta Clin Belg. 2023. PMID: 36573787
Cited by
-
Screening Test on Metabolic Syndrome Using Electro Interstitial Scan Instrument.Med Devices (Auckl). 2020 Sep 3;13:237-243. doi: 10.2147/MDER.S268948. eCollection 2020. Med Devices (Auckl). 2020. PMID: 32943950 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical